🇺🇸 GTN patch in United States

15 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chest Pain — 3 reports (20%)
  2. Acute Pulmonary Oedema — 2 reports (13.33%)
  3. Iron Deficiency Anaemia — 2 reports (13.33%)
  4. Troponin Normal — 2 reports (13.33%)
  5. Acidosis — 1 report (6.67%)
  6. Acute Myocardial Infarction — 1 report (6.67%)
  7. Agitation — 1 report (6.67%)
  8. Anaemia — 1 report (6.67%)
  9. Angina Pectoris — 1 report (6.67%)
  10. Aortic Stenosis — 1 report (6.67%)

Source database →

GTN patch in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is GTN patch approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for GTN patch in United States?

University Hospital Birmingham is the originator. The local marketing authorisation holder may differ — check the official source linked above.